Stryker Shareholders Approve Amendments at Annual Meeting

Stryker ( (SYK) ) has shared an announcement.

At the Annual Meeting of Shareholders held on May 8, 2025, Stryker Corporation’s shareholders approved amendments to several incentive and stock purchase plans, increasing the number of shares available and extending the plans’ duration. Additionally, all ten directors were re-elected, Ernst & Young LLP was ratified as the independent auditor, and a resolution on executive compensation was approved, while a proposal on political spending transparency was not presented.

The most recent analyst rating on (SYK) stock is a Buy with a $392.00 price target. To see the full list of analyst forecasts on Stryker stock, see the SYK Stock Forecast page.

Spark’s Take on SYK Stock

According to Spark, TipRanks’ AI Analyst, SYK is a Outperform.

Stryker’s overall stock score reflects its strong financial performance and robust earnings outlook, supported by significant growth in key segments and successful M&A integration. While the stock exhibits positive technical trends, its high valuation and external challenges such as tariffs and supply chain issues are notable risks. The positive earnings call sentiment and strategic initiatives bolster confidence in future growth.

To see Spark’s full report on SYK stock, click here.

More about Stryker

Stryker Corporation operates in the medical technology industry, providing a range of products and services including surgical equipment, neurotechnology, and orthopedic implants, with a focus on improving healthcare outcomes.

Average Trading Volume: 1,681,252

Technical Sentiment Signal: Buy

Current Market Cap: $148.3B

See more insights into SYK stock on TipRanks’ Stock Analysis page.